4737 Stock Overview
Designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Bionime Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$69.90 |
| 52 Week High | NT$79.80 |
| 52 Week Low | NT$60.80 |
| Beta | 0.60 |
| 11 Month Change | -2.92% |
| 3 Month Change | 4.33% |
| 1 Year Change | -10.04% |
| 33 Year Change | 5.11% |
| 5 Year Change | -3.32% |
| Change since IPO | 3.91% |
Recent News & Updates
Recent updates
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2
Jul 22
Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year
Jul 01These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24Shareholder Returns
| 4737 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 4.6% | -0.5% | -0.8% |
| 1Y | -10.0% | 1.5% | 29.0% |
Return vs Industry: 4737 underperformed the TW Medical Equipment industry which returned 1.5% over the past year.
Return vs Market: 4737 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 4737 volatility | |
|---|---|
| 4737 Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4737 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4737's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Roy Huang | www.bionime.com |
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors and self-monitors, as well as accessories, such as test strips and lancing devices for hospital and clinical use. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments.
Bionime Corporation Fundamentals Summary
| 4737 fundamental statistics | |
|---|---|
| Market cap | NT$4.26b |
| Earnings (TTM) | -NT$83.24m |
| Revenue (TTM) | NT$1.92b |
2.2x
P/S Ratio-51.2x
P/E RatioIs 4737 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4737 income statement (TTM) | |
|---|---|
| Revenue | NT$1.92b |
| Cost of Revenue | NT$1.12b |
| Gross Profit | NT$796.58m |
| Other Expenses | NT$879.82m |
| Earnings | -NT$83.24m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.36 |
| Gross Margin | 41.46% |
| Net Profit Margin | -4.33% |
| Debt/Equity Ratio | 158.8% |
How did 4737 perform over the long term?
See historical performance and comparison